Meatly Creates a Method to Reduce the Cost of Cultivated Meat

The company has completed the startup and first cell growth cycle in its new low-cost, 320-liter pilot-scale bioreactor. The patented bioreactor, designed internally by Meatly's R&D team, offers the biocompatibility, durability, scalability, and overall performance that the company needs for cellular cultivation in industrial production. It will replace the use of biopharmaceutical bioreactors, which have a high price and have been a significant barrier for many cultivated meat companies. The new bioreactor costs Meatly £12,500 (approximately $16,897 USD), compared to traditional bioreactors, which can cost around £250,000 (approximately $337,947 USD), representing a cost reduction of approximately 95%. Based on this new bioreactor, Meatly plans to develop multiple 20,000-liter bioreactors to increase Meatly Chicken production. Additionally, Meatly announced that it has further reduced the cost of its protein medium, used to create its cultivated chicken ingredient, to £0.22 (30¢ ...